PBH posted Q3 EPS of $1.14, down 6.6% and missing estimates, while revenues beat expectations. PBH's North American OTC sales fell on weak Clear Eyes supply, while International OTC rose 7.2%. PBH ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
PBH posted Q4 adjusted EPS of $1.23 and revenues of $281.6M, both missing consensus estimates. PBH sales slid as Clear Eyes supply limits hit Eye & Ear Care and Middle East shipping disruptions ...
Zacks Investment Research on MSN
Why is Prestige Consumer Healthcare (PBH) up 3.6% since last earnings report?
It has been about a month since the last earnings report for Prestige Consumer Healthcare (PBH). Shares have added about 3.6% in that time frame, outperforming the S&P 500. Will the recent positive ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Prestige Consumer Healthcare Inc. PBH delivered third-quarter fiscal 2026 diluted earnings per share (EPS) of $1.14, down 6.6% from the year-ago period’s figure. The metric also missed the Zacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results